Precision BioSciences, Inc.
DTIL·NasdaqCM·Healthcare
6.53−0.19 (−2.83%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours6.530.00 (0.00%)Oct 12, 4:01 PM EDT
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close6.72
Open6.71
Day range6.456.73
52-week range3.539.62
Off day high−2.96%
Off 52-week high−32.12%
Volume228.77K
Avg. volume (3M)282.20K
Market cap180.24M
EPS (TTM)-1.35
Forward P/E-3.51
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.28
Shares outstanding27.60M
Short interest9.33% of float
Earnings dateAug 6, 2026 (est.)
Analyst target29.40
Profit margin−117.04%
Against its peers
Compare in full ›| DTIL | PRQR | PRME | EDIT | NTLA | SCTX | |
|---|---|---|---|---|---|---|
| Market cap | 180.24M | 228.61M | 654.77M | 422.35M | 1.76B | 391.32M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -3.5 | -3.4 | -4.1 | -3.7 | -4.9 | -5.7 |
| Price/book | 3.8 | 2.6 | 16.0 | 4.0 | 2.4 | -0.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +20.86% | −28.82% | −29.38% | −18.54% | −47.36% | +11.60% |
| Today | −2.83% | −0.61% | −9.52% | −5.17% | −3.75% | −2.36% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All DTIL news ›Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting 2026
Precision BioSciences (Nasdaq: DTIL) will deliver a late-breaking oral presentation on PBGENE-HBV at AASLD’s The Liver Meeting on November 8, 2026. Details of the oral presentation: Further details on the trial can be found on Precision’s…
From articles in the 4Search news index.